MOSCOW (Reuters) – Russia’s sovereign wealth fund said on Tuesday it had agreed to supply 25 million doses of its potential COVID-19 vaccine to Nepal via Trinity Pharmaceuticals, which it described as a private healthcare firm and key distributor there.
The Russian Direct Investment Fund has struck multiple Sputnik V vaccine supply deals abroad, including to supply 100 million doses to India, where it also expects to hold clinical trials.
(Reporting by Maxim Rodionov; Writing by Polina Ivanova; Editing by Gareth Jones)
